vs

Side-by-side financial comparison of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) and Meridian Corp (MRBK). Click either name above to swap in a different company.

Meridian Corp is the larger business by last-quarter revenue ($34.2M vs $22.6M, roughly 1.5× KESTRA MEDICAL TECHNOLOGIES, LTD.). Meridian Corp runs the higher net margin — 428.0% vs -145.3%, a 573.3% gap on every dollar of revenue. Meridian Corp produced more free cash flow last quarter ($22.6M vs $-25.6M).

Kestra Medical Technologies, Ltd. is a medical device firm that develops, manufactures and commercializes innovative minimally invasive therapeutic solutions, mainly for interventional cardiology and structural heart disease treatment. It operates across North America, Europe and key Asia-Pacific markets, serving global healthcare providers and patients.

Meridian Audio is a consumer audio and home theatre equipment manufacturer based in the United Kingdom. Bob Stuart and Allen Boothroyd founded the company in 1977 under the name Boothroyd-Stuart. In 1985 the company released a CD player under the brand name, Meridian. The company also created the lossless compression format Meridian Lossless Packing in 1998 and the lossy Master Quality Authenticated (MQA) format in 2014.

KMTS vs MRBK — Head-to-Head

Bigger by revenue
MRBK
MRBK
1.5× larger
MRBK
$34.2M
$22.6M
KMTS
Higher net margin
MRBK
MRBK
573.3% more per $
MRBK
428.0%
-145.3%
KMTS
More free cash flow
MRBK
MRBK
$48.2M more FCF
MRBK
$22.6M
$-25.6M
KMTS

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
KMTS
KMTS
MRBK
MRBK
Revenue
$22.6M
$34.2M
Net Profit
$-32.8M
$7.2M
Gross Margin
50.6%
Operating Margin
-140.7%
27.2%
Net Margin
-145.3%
428.0%
Revenue YoY
5.1%
Net Profit YoY
28.3%
EPS (diluted)
$-0.64
$0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KMTS
KMTS
MRBK
MRBK
Q4 25
$22.6M
$34.2M
Q3 25
$19.4M
$33.1M
Q2 25
$32.4M
Q1 25
$27.1M
Q4 24
$32.6M
Q3 24
$29.1M
Q2 24
$26.1M
Q1 24
$24.6M
Net Profit
KMTS
KMTS
MRBK
MRBK
Q4 25
$-32.8M
$7.2M
Q3 25
$-25.8M
$6.7M
Q2 25
$5.6M
Q1 25
$2.4M
Q4 24
$5.6M
Q3 24
$4.7M
Q2 24
$3.3M
Q1 24
$2.7M
Gross Margin
KMTS
KMTS
MRBK
MRBK
Q4 25
50.6%
Q3 25
45.7%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
KMTS
KMTS
MRBK
MRBK
Q4 25
-140.7%
27.2%
Q3 25
-149.1%
26.2%
Q2 25
22.5%
Q1 25
11.6%
Q4 24
23.3%
Q3 24
21.5%
Q2 24
16.8%
Q1 24
14.4%
Net Margin
KMTS
KMTS
MRBK
MRBK
Q4 25
-145.3%
428.0%
Q3 25
-133.3%
20.1%
Q2 25
17.2%
Q1 25
8.9%
Q4 24
366.8%
Q3 24
16.3%
Q2 24
12.7%
Q1 24
10.9%
EPS (diluted)
KMTS
KMTS
MRBK
MRBK
Q4 25
$-0.64
$0.61
Q3 25
$-0.50
$0.58
Q2 25
$0.49
Q1 25
$0.21
Q4 24
$0.49
Q3 24
$0.42
Q2 24
$0.30
Q1 24
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KMTS
KMTS
MRBK
MRBK
Cash + ST InvestmentsLiquidity on hand
$175.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$164.1M
$199.7M
Total Assets
$246.7M
$2.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KMTS
KMTS
MRBK
MRBK
Q4 25
$175.4M
Q3 25
$201.2M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
KMTS
KMTS
MRBK
MRBK
Q4 25
$164.1M
$199.7M
Q3 25
$184.2M
$188.0M
Q2 25
$178.0M
Q1 25
$173.6M
Q4 24
$171.5M
Q3 24
$167.4M
Q2 24
$162.4M
Q1 24
$159.9M
Total Assets
KMTS
KMTS
MRBK
MRBK
Q4 25
$246.7M
$2.6B
Q3 25
$266.3M
$2.5B
Q2 25
$2.5B
Q1 25
$2.5B
Q4 24
$2.4B
Q3 24
$2.4B
Q2 24
$2.4B
Q1 24
$2.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KMTS
KMTS
MRBK
MRBK
Operating Cash FlowLast quarter
$-18.3M
$24.3M
Free Cash FlowOCF − Capex
$-25.6M
$22.6M
FCF MarginFCF / Revenue
-113.5%
65.9%
Capex IntensityCapex / Revenue
32.2%
5.1%
Cash ConversionOCF / Net Profit
3.38×
TTM Free Cash FlowTrailing 4 quarters
$51.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KMTS
KMTS
MRBK
MRBK
Q4 25
$-18.3M
$24.3M
Q3 25
$-26.3M
$24.4M
Q2 25
$-12.0M
Q1 25
$18.1M
Q4 24
$9.6M
Q3 24
$31.2M
Q2 24
$-19.2M
Q1 24
$-1.7M
Free Cash Flow
KMTS
KMTS
MRBK
MRBK
Q4 25
$-25.6M
$22.6M
Q3 25
$-34.4M
$24.0M
Q2 25
$-12.7M
Q1 25
$17.9M
Q4 24
$9.0M
Q3 24
$29.5M
Q2 24
$-19.3M
Q1 24
$-3.6M
FCF Margin
KMTS
KMTS
MRBK
MRBK
Q4 25
-113.5%
65.9%
Q3 25
-177.8%
72.4%
Q2 25
-39.1%
Q1 25
65.9%
Q4 24
27.7%
Q3 24
101.4%
Q2 24
-73.8%
Q1 24
-14.7%
Capex Intensity
KMTS
KMTS
MRBK
MRBK
Q4 25
32.2%
5.1%
Q3 25
42.2%
1.4%
Q2 25
1.9%
Q1 25
1.0%
Q4 24
1.7%
Q3 24
6.0%
Q2 24
0.2%
Q1 24
7.8%
Cash Conversion
KMTS
KMTS
MRBK
MRBK
Q4 25
3.38×
Q3 25
3.66×
Q2 25
-2.15×
Q1 25
7.55×
Q4 24
1.71×
Q3 24
6.58×
Q2 24
-5.78×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons